TTM
$819.56M
YoY change
+66.7%
5Y CAGR
+29.8%
Peak year (2025)
$606.42M
Cumulative revenue
$2.39B
Revenue history chart for Insmed (INSM) from 1999 to 2025
Latest: $606.42M
Revenue growth chart for Insmed (INSM) from 1999 to 2025
Latest: +66.7%
Revenue history table for Insmed (INSM) from 1999 to 2025
| 2025 | $606.42M | +66.7% | +$242.72M | ||
| 2024 | $363.71M | +19.2% | +$58.50M | ||
| 2023 | $305.21M | +24.4% | +$59.85M | ||
| 2022 | $245.36M | +30.2% | +$56.90M | ||
| 2021 | $188.46M | +14.6% | +$24.05M | ||
| 2020 | $164.41M | +20.5% | +$27.95M | ||
| 2019 | $136.47M | +1287.6% | +$126.63M | ||
| 2018 | $9.84M | — | +$9.84M | ||
| 2017 | $0.00 | — | $0.00 | ||
| 2016 | $0.00 | — | $0.00 | ||
| 2015 | $0.00 | -100.0% | −$11.50M | ||
| 2014 | $11.50M | 0.0% | $0.00 | ||
| 2013 | $11.50M | — | +$11.50M | ||
| 2012 | $0.00 | -100.0% | −$4.42M | ||
| 2011 | $4.42M | -36.2% | −$2.50M | ||
| 2010 | $6.92M | -33.3% | −$3.45M | ||
| 2009 | $10.37M | -11.3% | −$1.33M | ||
| 2008 | $11.70M | +55.4% | +$4.17M | ||
| 2007 | $7.53M | +659.7% | +$6.54M | ||
| 2006 | $991.00K | +656.5% | +$860.00K | ||
| 2005 | $131.00K | -4.4% | −$6.00K | ||
| 2004 | $137.00K | -8.7% | −$13.00K | ||
| 2003 | $150.00K | -92.3% | −$1.80M | ||
| 2002 | $1.96M | +560.5% | +$1.66M | ||
| 2001 | $296.00K | +393.3% | +$236.00K | ||
| 2000 | $60.00K | +5900.0% | +$59.00K | ||
| 1999 | $1.00K | — | — |
- 2025$606.42M+66.7%
- 2024$363.71M+19.2%
- 2023$305.21M+24.4%
- 2022$245.36M+30.2%
- 2021$188.46M+14.6%
- 2020$164.41M+20.5%
- 2019$136.47M+1287.6%
- 2018$9.84M—
- 2017$0.00—
- 2016$0.00—
- 2015$0.00-100.0%
- 2014$11.50M0.0%
- 2013$11.50M—
- 2012$0.00-100.0%
- 2011$4.42M-36.2%
- 2010$6.92M-33.3%
- 2009$10.37M-11.3%
- 2008$11.70M+55.4%
- 2007$7.53M+659.7%
- 2006$991.00K+656.5%
- 2005$131.00K-4.4%
- 2004$137.00K-8.7%
- 2003$150.00K-92.3%
- 2002$1.96M+560.5%
- 2001$296.00K+393.3%
- 2000$60.00K+5900.0%
- 1999$1.00K—
Revenue values are taken from Insmed's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Insmed (INSM)
According to Insmed's latest reported financial statements, the company's current revenue (TTM) is $819.56M. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual revenue for Insmed (INSM) came in at $606.42M – surged 66.7% year-over-year.
Insmed revenue has grown for 8 consecutive years, with a +29.8% compound annual growth rate over 2020–2025 (5 years).
$606.42M stands as the all-time-high annual revenue, posted in 2025, against a low of $0.00 during 2012.
Insmed Revenue by Year
Insmed Revenue 2025: $606.42M
2025's revenue for Insmed came in at $606.42M, surged 66.7% from 2024. This figure represents the highest annual value in the available history.
Insmed Revenue 2024: $363.71M
Insmed posted revenue of $363.71M in 2024, grew 19.2% from 2023.
Insmed Revenue 2023: $305.21M
In 2023, Insmed reported revenue of $305.21M, grew 24.4% from 2022.
Insmed Revenue 2022: $245.36M
Insmed revenue in 2022 was $245.36M, surged 30.2% from 2021.
Insmed Revenue 2021: $188.46M
Insmed revenue in 2021 was $188.46M.
See more financial history for Insmed (INSM).
Sector peers by Revenue
Healthcare peers of Insmed (INSM), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Insmed (INSM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation